Category Archives: Hepatitis C

09.10.19

Hepatitis Policy Project Releases New Brief on Expanding Syringe Service Programs as an Essential Tool to Achieve Hepatitis C Elimination in the U.S.

By | Leave a Comment

Institute Senior Associate Sonia Canzater and Infectious Diseases Initiative Program Director Jeffrey S. Crowley have authored the Hepatitis Policy Project’s latest “Big Ideas” issue brief that explains how expanding the number of syringe service programs (SSPs) is essential to improve the health of people with substance use disorder and stop the spread of hepatitis C […]

Posted in Hepatitis C, Hepatitis C News and Research, Hepatitis C News and Research, Hepatitis C Staff Insights ; Tagged: .

01.23.19

Living in Fear of News Headlines: The Struggle to Maintain Mental and Emotional Health in Today’s Hostile Social Climate

By | Leave a Comment

I am scheduled to write a post to this blog about once a month. I usually scan through the most recent headlines in public health and health care to write about a timely issue. However, of late I have been overwhelmed by the amount of bleak information in today’s news – spanning from the mildly […]

Posted in Hepatitis C, Hepatitis C Staff Insights ; Tagged: , .

12.21.18

While Lawmakers Focus on Fixing the Opioid Epidemic in Rural White America, Urban Black Men are Falling Victim to it at Catastrophic Rates… And No One Seems to Care

By | Leave a Comment

Recent reports released by the CDC and the Washington, DC Medical Examiner’s Office are sounding the alarm of the toll opioid drug misuse is having on the lives of District residents. The CDC reports that Washington, DC has one of the highest rates of drug overdose deaths in the U.S., at 44.0 deaths per 100,000 […]

Posted in Addiction, Hepatitis C, Hepatitis C Staff Insights ; Tagged: .

11.05.18

Being Sick Can Land You in Jail: Hepatitis C Criminalization

By | Leave a Comment

Several U.S. states have laws that criminalize knowingly exposing another to viral hepatitis or other infectious diseases. The definitions of the crimes and severity of penalties vary. Some states specifically target diseases such as HIV and viral hepatitis in the statutes, while others impose penalties for exposing others to any infectious diseases.  While opinions on […]

Posted in Hepatitis C, Hepatitis C News and Research, Hepatitis C Staff Insights, Infectious Diseases ; Tagged: .

09.20.18

Congress Passes Major Opioid Response Legislation that Includes Funding to Improve Infectious Disease Surveillance

By | Leave a Comment

Monday, the Senate passed the Opioid Crisis Response Act by a 99-1 vote. The Act provides many changes to several federal health and human service programs to address opioid and substance use disorders. A critical component of this legislation is the inclusion of a $40 million appropriation from 2019-2023 to the Centers for Disease Control and […]

Posted in Hepatitis C, HIV, Infectious Diseases ; Tagged: .

08.09.18

New Study Develops The Most Comprehensive Dataset of U.S. Hepatitis C Patients and Epidemiology

By | Leave a Comment

A recent study published in July 2018 in the journal Advances in Therapy discusses the findings made by researchers who compiled the most comprehensive dataset available to describe the current hepatitis C landscape in the U.S. The study covers from 2013-2016, and, among other concerning statistics, shows a 234% increase in confirmed hepatitis C positive patients […]

Posted in Health reform, Healthcare, Hepatitis C, Infectious Diseases ; Tagged: , .

07.26.18

July 28 is World Hepatitis Day – Take the Time to LEARN MORE and DO MORE to Eliminate Viral Hepatitis Across the Globe

By | Leave a Comment

This Saturday, July 28th is World Hepatitis Day. It is a time to reflect on the global impact of viral hepatitis, and to raise awareness of the continued need for legislators and health care leaders to support measures that improve access to prevention, screening, and treatment of hepatitis infections.  The World Health Organization (WHO) estimates […]

Posted in Hepatitis C ; Tagged: , , .

07.11.18

A Need for Greater Participation of States in Handling the Hepatitis C Epidemic

By | Leave a Comment

This blog post was authored by Dr. Daniel Lising, Research Assistant for the O’Neill Institute’s Hepatitis Policy Project. Daniel is a graduate of Georgetown University Law Center with an LL.M in Global Health Law. As the scourge of the opioid crisis continues, an often-overlooked consequence is the increased proliferation of blood borne illnesses such as […]

Posted in Hepatitis C, Hepatitis C Staff Insights, uncategorized ;

05.31.18

Hepatitis Policy Project Releases New Report Telling the Stories of People Affected by Hepatitis C

By | Leave a Comment

The Institute’s Hepatitis Policy Project has released a new report that features the stories of people affected by hepatitis C. The report was authored by Sonia Canzater and Jeffrey S. Crowley. “Full of Life: The Stories of People Affected by Hepatitis C,” underscores the impact of hepatitis C and the potential for improving the lives of those with […]

Posted in Hepatitis C, Hepatitis C Staff Insights ; Tagged: , , .

04.03.18

Elimination Without Prevention — Mission Impossible

By | Leave a Comment

This article was written by Thelma Thiel, Founder and Chair of the Liver Health Initiative. Viewpoints included in this article do not necessarily reflect those of the O’Neill Institute, the Hepatitis Policy Project or its sponsors.  All the media attention highlighting the dramatic increase in opioid and other drug addition, as well as the rising […]

Posted in Hepatitis C, uncategorized ; Tagged: .

Stay Informed

Signup for our mailing list and stay up to date on the latest happenings at The O’Neill Institute

Or sign up for our RSS Feed

The views reflected in this blog are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.

See the full disclaimer and terms of use.